Navigation Links
No Proof That 'Doping' With EPO Gives Athletes an Edge: Review
Date:12/7/2012

FRIDAY, Dec. 7 (HealthDay News) -- Erythropoietin, more commonly known as EPO, has been banned from sports due to a belief that it provides an unfair competitive advantage to users, but new research found there is no scientific evidence the blood-cell stimulating hormone actually enhances athletes' performance.

EPO has been in the news recently because of its reported use by the American cyclist Lance Armstrong, who won the Tour de France a record-breaking seven times. He was stripped of those titles in October.

While the scientists who conducted a systemic review of existing studies on EPO did not find proof of performance-enhancing benefits, they did find that possible harm from use of the hormone was well-documented.

In their report, published in the Dec. 6 issue of the British Journal of Clinical Pharmacology, they warned that EPO doping thickens the blood and could increase a person's risk for clots, which could result in heart attack or stroke.

"Athletes and their medical staff may believe EPO enhances performance, but there is no evidence that anyone performed good experiments to check if EPO would actually improve performance in elite cyclists," lead researcher Dr. Adam Cohen, of the Centre for Human Drug Research in Leiden, the Netherlands, said in a journal news release.

EPO is a drug used to treat anemia. Patients treated with EPO are carefully monitored due to the drug's potentially serious side effects.

"So why should the standards be different for the same drugs used in athletes?" noted Cohen. "Although doping is forbidden, the pressure to win in sport is so great that some athletes seem to be willing to try any way of getting ahead of their competitors. When elite athletes and their coaches discover that there is no evidence of benefit and clear risk of harm, I hope many may reconsider trying to cheat. Education may work where attempts at enforcement have failed," he said in the
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. No Proof That Gum Disease Causes Heart Disease, Experts Say
2. More Proof That Healthy Habits Fight Disease
3. More Proof Cranberry Juice Thwarts Infection
4. No proof that patients lose weight after joint replacement surgery
5. Vandetanib in thyroid cancer: No proof of added benefit
6. Could Gene Doping Be Part of Future Olympics?
7. London Olympics anti-doping labs set for first-of-a-kind repurposing
8. U.S. Gives Green Light to Publish Controversial Bird Flu Research
9. Image share project gives patients and physicians anytime, anywhere access to medical images
10. Procedure gives patients with A-fib who cant take blood thinners alternative to reduce stroke
11. UMD team gives drug dropouts a second chance
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
No Proof That 'Doping' With EPO Gives Athletes an Edge: Review
(Date:9/18/2014)... Savannah, GA (PRWEB) September 18, 2014 ... awarded the Alex Ormond, Jr. Leadership Award by the ... toward improving healthcare and wellness throughout the nation and ... to receive this award,” said Ben. “The Savannah Science ... for 65 years and multiple generations have gone through ...
(Date:9/18/2014)... will convene a one-day conference at the Milken Institute ... on September 25, 2014 to discuss the Global Health ... The purpose of this event is to invite discussion ... five years, including action plans to curtail the current ... the GHSA, international organizations and more than 50 countries ...
(Date:9/18/2014)... the Ebola virus invoke scary scenarios of deadly epidemics, ... are still providing researchers with new insights on how ... published online Sept. 18, 2014, in the journal ... Medical School Singapore detail how the Yersinia pestis bacteria ... the lymph nodes and eventually ride into the lungs ...
(Date:9/18/2014)... 18, 2014 As testosterone treatment ... U.S. courts, Bernstein Liebhard LLP notes that a ... Food & Drug Administration (FDA) subject prescription low ... could greatly reduce their use. The joint meeting ... Advisory Committee, and the Drug Safety and Risk ...
(Date:9/18/2014)... Once again, Hickman’s Family Farms will partner with ... to celebrate PJs & Eggs. The sixth annual event ... 10, 2014. The “breakfast for dinner” will begin at ... Association (AzCA) foster care programs statewide. , Customers ... on October 10 are invited to wear their pajamas ...
Breaking Medicine News(10 mins):Health News:Quirk Awarded the Alex Ormond, Jr. Leadership Award by the Savannah Science Seminar 2Health News:Non-governmental stakeholders to discuss the Global Health Security Agenda 2Health News:New insights on an ancient plague could improve treatments for infections 2Health News:Testosterone Treatment News: Bernstein Liebhard LLP Notes Experts’ Recommendations for New Restrictions on Low Testosterone Therapy 2Health News:Testosterone Treatment News: Bernstein Liebhard LLP Notes Experts’ Recommendations for New Restrictions on Low Testosterone Therapy 3Health News:Testosterone Treatment News: Bernstein Liebhard LLP Notes Experts’ Recommendations for New Restrictions on Low Testosterone Therapy 4Health News:October 10th Is 6th Annual PJs & Eggs: Hickman’s Family Farms and Breakfast Restaurants Partner to Benefit Arizona Foster Children 2
... , , ARMONK, N.Y., Dec. 22 ... arm, IBM Global Financing, has entered into new financing agreements with ... for private financing for health IT and the pressing challenges hospitals ... http://www.newscom.com/cgi-bin/prnh/20090416/IBMLOGO ) , Siemens Healthcare , Lavender ...
... KANSAS CITY, Mo., Dec. 22 During this ... not been immune to public scrutiny and fiscal pressures. The ... of insurance, creating skepticism and frustration for many policyholders who ... and their families. , As the new year approaches, ...
... DES MOINES, Iowa, Dec. 22 Palisade Systems, the leader ... enterprise, has completed internal certification of its PacketSure 7.6 service ... network services and software. , More and more companies are ... a recent article in eMarketer, close to 70 percent of ...
... , ... Avery Dennison Specialty Tape has,developed a proprietary adhesive technology that ... of ultra-thin hydrocolloid,adhesives delivers real consumer benefits in terms of ... the dressing, and,gentle removal. , High-performance ...
... ... cancer, the nation’s leading cause of cancer deaths for women and men ... no approved early detection tests for lung cancer. With a 5-year ... changed in 40 years. A new organization, Lung Cancer Foundation of ...
... , ... acknowledged for its overall appeal and site design. , ... Englewood, CO (Vocus) December 22, 2009 -- The ... , ,The 2009 eHealthcare awards were presented by Strategic Health Care Communications as a ...
Cached Medicine News:Health News:IBM Financing Agreements With Electronic Healthcare Record Providers Shatter Barriers To Health IT Adoption 2Health News:IBM Financing Agreements With Electronic Healthcare Record Providers Shatter Barriers To Health IT Adoption 3Health News:IBM Financing Agreements With Electronic Healthcare Record Providers Shatter Barriers To Health IT Adoption 4Health News:IBM Financing Agreements With Electronic Healthcare Record Providers Shatter Barriers To Health IT Adoption 5Health News:After Tough 2009, Improved Accountability and Consistent Insurance Industry Standards Key in 2010 2Health News:After Tough 2009, Improved Accountability and Consistent Insurance Industry Standards Key in 2010 3Health News:After Tough 2009, Improved Accountability and Consistent Insurance Industry Standards Key in 2010 4Health News:Palisade PacketSure Certified for Twitter and Facebook 2Health News:Avery Dennison Innovates in Consumer Wound Care 2Health News:Avery Dennison Innovates in Consumer Wound Care 3Health News:Lung Cancer Foundation of America Gives the Gift of Life This Holiday Season: Announces Inaugural $125,000 Scientific Research Grant 2Health News:Lung Cancer Foundation of America Gives the Gift of Life This Holiday Season: Announces Inaugural $125,000 Scientific Research Grant 3Health News:Lung Cancer Foundation of America Gives the Gift of Life This Holiday Season: Announces Inaugural $125,000 Scientific Research Grant 4Health News:Healthcare Web Site Wins Top Industry Awards 2
(Date:9/18/2014)... 18, 2014  Decision Resources Group finds that ... United States , 54 percent of surveyed ... Tafinlar for BRAF -mutation-positive unresectable or metastatic ... GlaxoSmithKline,s MEK inhibitor Mekinist. Among current non-prescribers of ... and 43 percent, respectively) expects to prescribe these ...
(Date:9/18/2014)... 2014  Iliad Neurosciences, Inc., a company focused on ... Autism Spectrum Disorders (ASD) announced today that it has ... Foundation for The State University of New York. ... biomarker to identify an abnormality in folate transport to ... is expected to be available for research use by ...
(Date:9/18/2014)... Mass. , Sept. 18, 2014  Decision Resources ... anti-vascular endothelial growth factor (VEGF) agent for wet AMD, ... Medicare Advantage plans as Genentech,s Lucentis, which is the ... surveyed managed care organization (MCO) directors do not identify ... is slightly more likely than Lucentis to be listed ...
Breaking Medicine Technology:At One Year Post-Launch, Approximately One Half of Surveyed U.S. Medical Oncologists Have Prescribed Single-Agent Tafinlar and Mekinist to Their Malignant Melanoma Patients 2Iliad Neurosciences, Inc. enters into an Exclusive License Agreement with The Research Foundation for The State University of New York 2Iliad Neurosciences, Inc. enters into an Exclusive License Agreement with The Research Foundation for The State University of New York 3Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD 2Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD 3
... -- China Sky One Medical, Inc. ("China Sky One" or ... integrated pharmaceutical company producing over-the-counter drugs in the People,s Republic ... quarter and fiscal year ended December 31, 2010. ... Highlights Total revenues decreased by $3.0 million, ...
... Saffron Technology, Inc. , a privately-held data analytics ... and government, today announced the addition of four ... .   "Our Executive Advisors possess ... broad knowledge of industries and markets important to ...
Cached Medicine Technology:China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 2China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 3China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 4China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 5China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 6China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 7China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 8China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 9China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 10China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 11China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 12China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 13China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 14Saffron Technology Adds Seasoned Business Executives to Advisory Board 2Saffron Technology Adds Seasoned Business Executives to Advisory Board 3
Polygraf ID Adapter Cable for LATITUDE® Air-Charged Catheter...
Solid State Manometry Catheter Accessory., ,Manometric calibrators are required for calibration of solid state catheters., ,Each type of catheter requires a unique calibrator....
Sphincter of Oddi Solid State Catheter Adapter Cable for Polygraf ID...
... The ITREL 3 is a battery ... in the U.S., ,Enterra™ Therapy is ... and vomiting associated with gastroparesis when conventional ... of symptons for diabetic or idiopathic patients., ...
Medicine Products: